Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 2/2005

01-03-2005 | Original Article

A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer

Authors: Joan Carles Galcerán, Romà Bastus Piulats, Javier Martín-Broto, Pablo Maroto Rey, Miquel Nogué Aligué, Montserrat Domenech Santasusana, Angels Arcusa Lanza, Joaquim Bellmunt Molins, Catherine Colin, Atika Girard

Published in: Clinical and Translational Oncology | Issue 2/2005

Login to get access
Metadata
Title
A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer
Authors
Joan Carles Galcerán
Romà Bastus Piulats
Javier Martín-Broto
Pablo Maroto Rey
Miquel Nogué Aligué
Montserrat Domenech Santasusana
Angels Arcusa Lanza
Joaquim Bellmunt Molins
Catherine Colin
Atika Girard
Publication date
01-03-2005
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 2/2005
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02710012

Other articles of this Issue 2/2005

Clinical and Translational Oncology 2/2005 Go to the issue

Educational Review

Wilms tumor: What’s new?

Original Articles

Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas. Preliminary results of a phase II, single-institutional trial

Original Articles

Carcinoma microcítico de localización extrapulmonar: ¿es su curso similar a los microcíticos pulmonares?

Review

Retrasos e interrupciones: La dificultad para irradiar en el tiempo ideal

Case Reports

Disnea, oliguria y edema en extremidades inferiores en paciente en tratamiento de radioterapia mediastínica por carcinoma tímico irresecable

Case Reports

Linitis plástica primaria rectal
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits